• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    1/29/21 12:49:48 PM ET
    $OAC
    Business Services
    Finance
    Get the next $OAC alert in real time by email
    SC 13G 1 thrive_capital.htm THRIVE CAPITAL PARTNERS V, L.P. / HIMS & HERS HEALTH -- SCHEDULE 13G

     

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

      (Amendment No.     ) *

     

     

    Hims & Hers Health, Inc.

    (Name of Issuer)

       

    Class A Common Stock, $0.0001 par value per share

     

    (Title of Class of Securities)

      

    433000 106

     

    (CUSIP Number)

      

    January 20, 2021

     

    (Date of Event Which Requires Filing of This Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐   Rule 13d-1(b)

    ☒   Rule 13d-1(c)

    ☐   Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No.  433000 106

    13G Page 2 of 10 Pages    

    1.  

    NAME OF REPORTING PERSON(S)

     

    Thrive Capital Partners V, L.P.

     

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

     

     

    (a) ☐

    (b) ☐

    3.  

    SEC USE ONLY

     

     

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware 

      

       
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
     

     5.

     

    SOLE VOTING POWER

     

    0 Shares

     

      6.  

    SHARED VOTING POWER

     

    15,389,541 Shares

     

      7.  

    SOLE DISPOSITIVE POWER

     

    0 Shares

     

      8.  

    SHARED DISPOSITIVE POWER

     

    15,389,541 Shares

     

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    15,389,541 Shares

     

       
    10.  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

     

       ☐
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      

    8.5%

     

       

     12.

     

    TYPE OF REPORTING PERSON

       

    PN

     

       

     

     

     

    CUSIP No.  433000 106

    13G Page 3 of 10 Pages    

    1.  

    NAME OF REPORTING PERSON(S)

     

    Claremount V Associates, L.P.

     

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

     

     

    (a) ☐

    (b) ☐

    3.  

    SEC USE ONLY

     

     

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware 

      

       
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
     

     5.

     

    SOLE VOTING POWER

     

    0 Shares

     

      6.  

    SHARED VOTING POWER

     

    15,389,541 Shares

     

      7.  

    SOLE DISPOSITIVE POWER

     

    0 Shares

     

      8.  

    SHARED DISPOSITIVE POWER

     

    15,389,541 Shares

     

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    15,389,541 Shares

     

       
    10.  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

     

       ☐
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      

    8.5%

     

       

     12.

     

    TYPE OF REPORTING PERSON

       

    PN

     

       

     

     

     

    CUSIP No.  433000 106

    13G Page 4 of 10 Pages    

    1.  

    NAME OF REPORTING PERSON(S)

     

    Thrive Partners V GP, LLC

     

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

     

     

    (a) ☐

    (b) ☐

    3.  

    SEC USE ONLY

     

     

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware 

      

       
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
     

     5.

     

    SOLE VOTING POWER

     

    0 Shares

     

      6.  

    SHARED VOTING POWER

     

    15,389,541 Shares

     

      7.  

    SOLE DISPOSITIVE POWER

     

    0 Shares

     

      8.  

    SHARED DISPOSITIVE POWER

     

    15,389,541 Shares

     

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    15,389,541 Shares

     

       
    10.  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

     

       ☐
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      

    8.5%

     

       

     12.

     

    TYPE OF REPORTING PERSON

       

    OO

     

       

     

     

     

    CUSIP No.  433000 106

    13G Page 5 of 10 Pages    

    1.  

    NAME OF REPORTING PERSON(S)

     

    Joshua Kushner

     

       
    2.  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

     

     

    (a) ☐

    (b) ☐

    3.  

    SEC USE ONLY

     

     

     

       
    4.  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America 

      

       
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY EACH
    REPORTING
    PERSON WITH:
     

     5.

     

    SOLE VOTING POWER

     

    0 Shares

     

      6.  

    SHARED VOTING POWER

     

    15,389,541 Shares

     

      7.  

    SOLE DISPOSITIVE POWER

     

    0 Shares

     

      8.  

    SHARED DISPOSITIVE POWER

     

    15,389,541 Shares

     

    9.  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    15,389,541 Shares

     

       
    10.  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

     

       ☐
    11.  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

      

    8.5%

     

       

     12.

     

    TYPE OF REPORTING PERSON

       

    IN

     

       

     

     

     

    CUSIP No.  433000 106

    13G Page 6 of 10 Pages    

     

     

    Item 1(a).Name of Issuer:

     

    Hims & Hers Health, Inc. (the “Issuer”)

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    2269 Chestnut Street, #523, San Francisco, California 94123

     

    Item 2(a).Names of Persons Filing:

     

    The names of the persons filing this report (collectively, the “Reporting Persons”) are:

    Thrive Capital Partners V, L.P. (“Thrive V”)

    Claremount V Associates, L.P. (“Claremount V”)

    Thrive Partners V GP, LLC (“Thrive GP”)

    Joshua Kushner (“Kushner”)

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    The address of the principal business office of each of the Reporting Persons is c/o Thrive Capital, 295 Lafayette Street, Suite 701, New York, NY 10012.

     

    Item 2(c).Citizenship:

     

    Each of Thrive V and Claremount V is a Delaware limited partnership. Thrive GP is a Delaware limited liability company. Kushner is a United States citizen.

     

    Item 2(d).Title of Class of Securities:

     

    Class A Common Stock, par value $0.0001 (“Class A Common Stock”)

     

    Item 2(e).CUSIP Number:

     

    433000 106

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

     

     

     

    CUSIP No.  433000 106

    13G Page 7 of 10 Pages    

     

     

     

     

    Item 4.Ownership.

     

    (a)Amount Beneficially Owned: As of January 20, 2021, Thrive V holds (i) 13,687,284 shares of Class A Common Stock, (ii) a warrant to purchase 84,027 shares of Class A Common Stock and (iii) 1,338,897 earn out shares that will vest into Class A Common Stock if the trading price of the Class A Common Stock meets certain price thresholds (collectively, the “Thrive V Shares”). As of January 20, 2021, Claremount V holds (i) 253,034 shares of Class A Common Stock, (ii) a warrant to purchase 1,551 shares of Class A Common Stock and (iii) 24,748 earn out shares that will vest into Class A Common Stock if the trading price of the Class A Common Stock meets certain price thresholds (collectively, the “Claremount V Shares”, and together with the Thrive V Shares, the “Shares”). By virtue of their relationship as affiliated entities and who share a controlling entity, Thrive V and Claremount V may be deemed to share the power to direct the disposition and vote of the Shares. Thrive V and Claremount V may therefore be deemed to beneficially own 15,389,541 shares of Class A Common Stock. As the sole general partner of Thrive V and Claremount V, Thrive GP may be deemed to beneficially own the Shares. As the sole managing member of Thrive GP, Kushner also may be deemed to beneficially own the Shares.

     

    (b)Percent of Class: See Line 11 of cover sheets. The percentages set forth on the cover sheet for each Reporting Person are calculated based on 181,572,813 shares deemed to be outstanding, which includes the (i) 181,487,235 outstanding shares of Class A Common Stock, (ii) Thrive V’s warrant to purchase 84,027 shares of Class A Common Stock and (iii) Claremount V’s warrant to purchase 1,551 shares of Class A Common Stock.

     

    (c)Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote: See Line 5 of cover sheets.

     

    (ii)shared power to vote or to direct the vote: See Line 6 of cover sheets.

     

    (iii)sole power to dispose or to direct the disposition of: See Line 7 of cover sheets.

     

    (iv)shared power to dispose or to direct the disposition of: See Line 8 of cover sheets.

     

    Each Reporting Person disclaims beneficial ownership of such Class A Common Stock except for the shares, if any, such Reporting Person holds of record.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

     

    Not applicable.

     

     

     

    CUSIP No.  433000 106

    13G Page 8 of 10 Pages    

     

     

     

     

     

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

     

     

     

     

     

     

     

    CUSIP No.  433000 106

    13G Page 9 of 10 Pages    

    SIGNATURE

     

     

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:     January 29, 2021

     

     

     

    THRIVE CAPITAL PARTNERS V, L.P.

     

    By:      Thrive Partners V GP, LLC

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

     

     

    CLAREMOUNT V ASSOCIATES, L.P.

     

    By:      Thrive Partners V GP, LLC

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

     

     

    THRIVE PARTNERS V GP, LLC

     

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

      

     

    /s/ Joshua Kushner                        

    Joshua Kushner

     

     

     

     

     

     

     

    CUSIP No.  433000 106

    13G Page 10 of 10 Pages    

     

    EXHIBIT 1

     

    AGREEMENT OF JOINT FILING

     

    Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of stock of Hims & Hers Health, Inc.

     

    Executed this 29th day of January, 2021.

     

     

    THRIVE CAPITAL PARTNERS V, L.P.

     

    By:      Thrive Partners V GP, LLC

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

     

     

    CLAREMOUNT V ASSOCIATES, L.P.

     

    By:      Thrive Partners V GP, LLC

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

     

     

    THRIVE PARTNERS V GP, LLC

     

     

    By:      /s/ Joshua Kushner                        

    Name: Joshua Kushner

    Title: Managing Member

     

      

     

    /s/ Joshua Kushner                        

    Joshua Kushner

     

     

     

     

     

    Get the next $OAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Certain Closed-end Funds Advised by Franklin Templeton Fund Adviser, LLC Announce Appointment of New Chair and Directors

      BrandywineGLOBAL – Global Income Opportunities Fund Inc. ("BWG") Clarion Partners Real Estate Income Fund Inc. ("CPREIF") ClearBridge Energy Midstream Opportunity Fund Inc. ("EMO") LMP Capital and Income Fund Inc. ("SCD") Western Asset Diversified Income Fund ("WDI") Western Asset Emerging Markets Debt Fund Inc. ("EMD") Western Asset Global Corporate Opportunity Fund Inc. ("GDO") Western Asset Global High Income Fund Inc. ("EHI") Western Asset High Income Fund II Inc. ("HIX") Western Asset High Income Opportunity Fund Inc. ("HIO") Western Asset High Yield Defined Opportunity Fund Inc. ("HYI") Western Asset Intermediate Muni Fund Inc. ("SBI") Western Asset Investment

      11/15/24 8:00:00 AM ET
      $BWG
      $DMO
      $EHI
      $EMD
      Finance/Investors Services
      Finance
      Trusts Except Educational Religious and Charitable
      Investment Managers
    • Oaktree Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

      NEW YORK--(BUSINESS WIRE)--Oaktree Acquisition Corp. (“OAC”) (NYSE: OAC), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, OAC is strongly encouraging that shareholders attend the extraordinary general meeting of OAC’s shareholders, which will be held on January 19, 2021 at 9:00 a.m., New York City Time (the “General Meeting”), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced Agreement and Plan of Merger, dated as of September 30, 2020 (as amended, the “Me

      1/12/21 7:45:00 AM ET
      $OAC
      Business Services
      Finance

    $OAC
    SEC Filings

    See more
    • SEC Form 8-K filed by Oaktree Acquisition Corp.

      8-K - Hims & Hers Health, Inc. (0001773751) (Filer)

      3/18/21 4:05:34 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form 424B3 filed

      424B3 - Hims & Hers Health, Inc. (0001773751) (Filer)

      3/10/21 4:05:19 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form 8-K filed

      8-K - Hims & Hers Health, Inc. (0001773751) (Filer)

      3/10/21 4:03:01 PM ET
      $OAC
      Business Services
      Finance

    $OAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed

      SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

      2/16/21 4:30:53 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form SC 13G/A filed

      SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

      2/16/21 3:09:49 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form SC 13G/A filed

      SC 13G/A - Hims & Hers Health, Inc. (0001773751) (Subject)

      2/16/21 1:27:52 PM ET
      $OAC
      Business Services
      Finance

    $OAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $OAC
    Leadership Updates

    Live Leadership Updates

    See more
    • SEC Form 3 filed by G Andrea Garcia Perez

      3 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      3/15/21 6:19:00 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form 3: Ambar Bhattacharyya claimed ownership of 1,709,092 units of Class A Common Stock

      3 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      3/15/21 6:14:54 PM ET
      $OAC
      Business Services
      Finance
    • SEC Form 3: Llc Xv, Management Venture Institutional claimed ownership of 20,373,064 units of Class A Common Stock

      3 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      2/2/21 6:11:49 AM ET
      $OAC
      Business Services
      Finance
    • Certain Closed-end Funds Advised by Franklin Templeton Fund Adviser, LLC Announce Appointment of New Chair and Directors

      BrandywineGLOBAL – Global Income Opportunities Fund Inc. ("BWG") Clarion Partners Real Estate Income Fund Inc. ("CPREIF") ClearBridge Energy Midstream Opportunity Fund Inc. ("EMO") LMP Capital and Income Fund Inc. ("SCD") Western Asset Diversified Income Fund ("WDI") Western Asset Emerging Markets Debt Fund Inc. ("EMD") Western Asset Global Corporate Opportunity Fund Inc. ("GDO") Western Asset Global High Income Fund Inc. ("EHI") Western Asset High Income Fund II Inc. ("HIX") Western Asset High Income Opportunity Fund Inc. ("HIO") Western Asset High Yield Defined Opportunity Fund Inc. ("HYI") Western Asset Intermediate Muni Fund Inc. ("SBI") Western Asset Investment

      11/15/24 8:00:00 AM ET
      $BWG
      $DMO
      $EHI
      $EMD
      Finance/Investors Services
      Finance
      Trusts Except Educational Religious and Charitable
      Investment Managers